SCLC, EXTENSIVE STAGE
Clinical trials for SCLC, EXTENSIVE STAGE explained in plain language.
Never miss a new study
Get alerted when new SCLC, EXTENSIVE STAGE trials appear
Sign up with your email to follow new studies for SCLC, EXTENSIVE STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hope for frail lung cancer patients: immunotherapy plus chemo shows promise
Disease control CompletedThis study looked at 70 people with advanced small cell lung cancer who were too weak for standard treatments. They received a combination of the immunotherapy drug atezolizumab plus chemotherapy. The goal was to see if this approach could help them live longer and control the ca…
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated May 26, 2026 11:58 UTC
-
New triple therapy shows promise for aggressive lung cancer
Disease control CompletedThis study tested a combination of two drugs (durvalumab and anlotinib) plus standard chemotherapy as a first treatment for people with extensive-stage small-cell lung cancer, a fast-growing cancer. 34 adults took part. The goal was to see if the combo could slow cancer growth be…
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated May 26, 2026 11:54 UTC